Agios Pharmaceuticals
$28.16
32
+$0.72+2.62% Monday 21:00
Statistics
Day High
28.69
Day Low
26.53
52W High
46
52W Low
22.24
Volume
851,472
Avg. Volume
1,647,490
Mkt Cap
1.64B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12FebExpected
Expected EPS
-1.953708
Actual EPS
N/A
Financials
1,845.92%Profit Margin
Profitable73MRevenue
1.35BNet Income
Analyst Ratings
$34.50Average Price Target
The highest estimate is 48.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 63%
Hold 38%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AGIO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Gilead Sciences
GILD
Mkt Cap148.78B
AMGEN
AMGN
Mkt Cap160.66B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Novartis
NVS
Mkt Cap237.61B
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Beam Therapeutics
BEAM
Mkt Cap2.53B
About
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Mr. Brian M. Goff M.B.A.
Employees
486
Country
US
ISIN
US00847X1046
Listings
0 Comments
Share your thoughts
FAQ
What is Agios Pharmaceuticals stock price today?▼
The current price of AGIO is $28.16 USD — it has increased by +2.62% in the past 24 hours. Watch Agios Pharmaceuticals stock price performance more closely on the chart.
What is Agios Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Agios Pharmaceuticals stocks are traded under the ticker AGIO.
Is Agios Pharmaceuticals stock price growing?▼
AGIO stock has fallen by -1.78% compared to the previous week, the month change is a +3.61% rise, over the last year Agios Pharmaceuticals has showed a -16.23% decrease.
What is Agios Pharmaceuticals market cap?▼
Today Agios Pharmaceuticals has the market capitalization of 1.64B
When is the next Agios Pharmaceuticals earnings date?▼
Agios Pharmaceuticals is going to release the next earnings report on February 12, 2026.
What were Agios Pharmaceuticals earnings last quarter?▼
AGIO earnings for the last quarter are -1.78 USD per share, whereas the estimation was -1.9 USD resulting in a +6.14% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Agios Pharmaceuticals revenue for the last year?▼
Agios Pharmaceuticals revenue for the last year amounts to 73M USD.
What is Agios Pharmaceuticals net income for the last year?▼
AGIO net income for the last year is 1.35B USD.
How many employees does Agios Pharmaceuticals have?▼
As of February 03, 2026, the company has 486 employees.
In which sector is Agios Pharmaceuticals located?▼
Agios Pharmaceuticals operates in the Health Care sector.
When did Agios Pharmaceuticals complete a stock split?▼
Agios Pharmaceuticals has not had any recent stock splits.
Where is Agios Pharmaceuticals headquartered?▼
Agios Pharmaceuticals is headquartered in Cambridge, US.